The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel

British Journal of Cancer

Volumn 84, Issue 4, 2001, Pages 478-481

  Figer, A ^a   Irmin, L ^a,b,c   Geva, R ^a   Flex, D ^a   Sulkes, J ^a   Sulkes, A ^a   Friedman, E ^b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

BRCA 2; Inherited predisposition to cancer; Jewish founder mutation; Non colon cancer

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; DIGESTIVE SYSTEM CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; JEWS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0035099690     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1605     Document Type: Article

References (26)

1. The founder mutation 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer among Ashkenazi women
2. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim
3. Cancer risks in BRCA2 mutation carriers
4. Cancer mortality in relatives of women with ovarian cancer: The OPCS Study. Office of Population Censuses and Surveys
5. Life-style risk factors for pancreatic cancer in Louisiana: A case-control study
6. Family history and the risk of liver, gallbladder, and pancreatic cancer
7. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada
8. Germlinc BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas
9. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
10. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer
11. Mutations in the BRCA2 gene in hepatocellular carcinomas
12. Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations
13. Family history and risk of stomach cancer in Warsaw, Poland
14. Familial pancreatic cancer. A family study
15. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
16. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
17. Family history and risk of stomach cancer in Italy
18. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families
19. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
20. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis
21. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
22. Founder BRCA1/2 mutations among male patients with breast cancer in Israel
23. Study of a single BRCA2 mutation with high carrier frequency in a small population
24. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer
25. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry